Xylocaine-MPF with Epinephrine 1:200 recall
Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25…
Why was Xylocaine-MPF with Epinephrine 1:200 recalled?
Low out of specification results for epinephrine assay.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Batch, expiry: Batch 6123435, exp 01/2022; 6124730, 6124731, exp 07/2022
- Product
- Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25…
- Recalling firm
- Fresenius Kabi USA LLC
- Quantity
- 234,800 vials
- Distribution
- Distributed Nationwide in the USA
- Recall date
- July 14, 2021
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)